턱성형술 시장 규모, 점유율, 동향 분석 보고서 : 시술별, 성별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Chin Augmentation Market Size, Share & Trends Analysis Report By Procedure (Surgical, Non-Surgical), By Gender (Female, Male), By End-use (Cosmetic Surgery Centers, Hospitals, MedSpas), By Region, And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,245,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,631,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,402,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

턱성형술 시장의 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 턱성형술 시장 규모는 2023년부터 2030년까지 CAGR 6.8%로 성장하여 2030년에는 20억 1,000만 달러에 달할 것으로 예상됩니다.

이 시장의 성장은 미적 요구의 변화, 규제 기관의 턱 확대용 피부 필러에 대한 인식, 제조업체와 다른 서비스 중개업체와의 협력 관계 확대에 기인합니다. 또한, 2020년 미국 성형외과학회(American Society of Plastic Surgeons)의 보고서에 따르면, 얼굴과 머리에 초점을 맞춘 다양한 미용 수술이 노화의 징후를 보이는 성인 인구가 선호하기 때문에 전 세계 고령화 인구의 증가는 턱성형술에 대한 수요를 촉진하고 있다, 히알루론산 기반 필러는 주로 40-54세 연령층에서 주로 사용됩니다.

미국, 독일 등 선진국에서는 월별 비용을 분산하여 성형수술에 대한 자금을 조달할 수 있기 때문에 환자들은 턱 확대와 같은 성형수술을 받는 경향이 있습니다. 또한, 주요 피부 필러 제조업체는 제품 대상에 대한 침투력을 높이기 위해 서비스 제공 업체와 적극적으로 협력하고 있습니다. 예를 들어, 2022년 4월 PatientFi와 Allergan Aesthetics는 마케팅 계약을 확대하여 전자가 후자의 제품 포트폴리오에 융자 옵션을 제공할 수 있도록 했습니다. 이 계약은 Volluma 및 Volux와 같은 쥬비덤 필러의 턱성형술에 대한 사용을 촉진할 것으로 예상됩니다.

또한, 턱 성형용 피부 필러에 대한 제품 승인이 증가하고 있는 것도 시장 성장에 힘을 보태고 있습니다. 예를 들어, 2020년 6월, 아비는 턱 성형용 주비덤 볼마(JUVIDERM Volluma)를 미국 FDA의 승인을 받았습니다. 마찬가지로 2021년 2월, Galderma는 21세 이상 성인의 중등도에서 경미한 턱 후퇴를 교정하는 Restylane Defyne에 대한 규제 당국의 승인을 획득했습니다.

턱성형술 시장 보고서 하이라이트

• 세계 시장은 2022년 12억 달러로 추정되며, 2030년에는 20억 1,000만 달러에 달할 것으로 예상됩니다.
• 2023년부터 2030년까지 세계 시장은 CAGR 6.8%로 성장할 것으로 예상됩니다.
• 2022년에는 북미 지역이 34.95%의 매출 점유율로 시장을 주도했습니다. 이러한 성장은 미용 시술에 대한 수용성 증가, 연방 규제 기관의 제품 승인 증가, 서비스 제공 업체 수 증가에 기인합니다.
• 2022년 매출 점유율은 수술 부문이 독주하여 시장의 69.62%를 차지했습니다.
• 미용외과 센터는 첨단 인프라, 짧은 대기 시간, 외래 환자 우선 서비스를 제공 할 수 있기 때문에 2022년 54.92%의 매출 점유율로 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 턱성형술 시장 변수, 동향 및 범위

• 시장 계통 전망
• 시장 동향과 전망
• 시장 역학
• 사업 환경 분석

제4장 턱성형술 시장 : 시술 비지니스 분석

• 턱성형술 시장 : 시술 동향과 시장 점유율 분석, 2022년과 2030년
• 수술
• 비수술

제5장 턱성형술 시장 : 성별 비지니스 분석

• 턱성형술 시장 : 성별 동향과 시장 점유율 분석, 2022년과 2030년
• 여성
• 남성

제6장 턱성형술 시장 : 최종 용도 비지니스 분석

• 턱성형술 시장 : 최종 용도 동향과 시장 점유율 분석, 2022년과 2030년
• 미용성형 센터
• 병원
• 메드스파

제7장 턱성형술 시장 : 지역 비지니스 분석

• 지역 시장 현황
• 국가별 시장 점유율 분석, 2022년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 상황

• 기업 분류
• 전략 매핑
• 기업 개요·리스트
  • New York Plastic Surgical Group
  • Westlake Dermatology &Cosmetic Surgery
  • Nazarian Plastic Surgery
  • Ruby Surgery &Aesthetics
  • Cadogan Clinics
  • UK Aesthetic
  • UK Healthcare Aesthetics Center
  • Marroquin &Sandoval Plastic Surgery
  • Advanced Cosmetic Surgery.
  • Orange County Facial Plastic Surgery.

ksm

영문 목차

영문목차

Chin Augmentation Market Growth & Trends:

The global chin augmentation market size is expected to reach USD 2.01 Billion by 2030, registering at a CAGR of 6.8% from 2023 to 2030, based on a new report by Grand View Research, Inc.. The growth of the market is attributed to the changing aesthetic needs, recognition of dermal fillers for chin augmentation by regulatory bodies, and growing collaboration between manufacturers and other service intermediaries. Moreover, the growing aging population globally propels the demand for chin augmentation as various aesthetic surgeries focused on the face and head are preferred by the adult population who portray signs of aging. According to the American Society of Plastic Surgeons report in 2020, hyaluronic acid-based fillers were used predominantly in those aged between 40 to 54 years.

The availability to finance cosmetic surgeries at distributed monthly cost propels patients to undergo cosmetic procedures such as chin augmentation in developed countries such as the U.S. and Germany. Furthermore, leading manufacturers of dermal fillers are actively collaborating with service providers to increase their product-target penetration. For instance, in April 2022, PatientFi and Allergan Aesthetics expanded their marketing agreement, allowing the former company to provide financing options to the latter's product portfolio. The agreement will propel the usage of Juvederm fillers such as Volluma and Volux for chin augmentation procedures.

In addition, growing product approvals for dermal fillers for chin augmentation applications propels the market growth. For instance, in June 2020, AbbVie received U.S. FDA approval for Juvederm Volluma to augment the chin. Similarly, in February 2021, Galderma received regulatory approval for Restylane Defyne to correct moderate to mild chin retrusion in adults aged 21 and over.

Chin Augmentation Market Report Highlights:

• The global market was estimated at USD 1.20 billion in 2022 and is expected to reach USD 2.01 billion in 2030
• The global market is expected to grow at a compound annual growth rate of 6.8% from 2023 to 2030
• In 2022, North America dominated the market in terms of a revenue share of 34.95%. This growth can be attributed to the increasing acceptability of cosmetic procedures, growing product approvals from federal regulatory bodies, and a rising number of service providers
• The surgical segment dominated the revenue share in 2022 and accounted for 69.62% in 2022 of the market
• Cosmetic surgery centers dominated the market with a revenue share of 54.92% in 2022, due to the availability of advanced infrastructure, shorter waiting time, and the ability to serve patients on an outpatient preference

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Volume Price Analysis
    • 1.5.1.1. Approach 1: Volume Price Analysis
• 1.6. Data Validation & Publishing
• 1.7. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Chin Augmentation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Advancement in surgical and non-surgical techniques
    • 3.3.1.2. Increasing product approvals from regulatory bodies
    • 3.3.1.3. Growing number of cosmetic procedures in aging & male population
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Stringent regulatory rule for providers
    • 3.3.2.2. High-cost variability across regions
• 3.4. Business Environment Analysis
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Chin Augmentation Market: Procedure Business Analysis

• 4.1. Chin Augmentation Market: Procedure Movement & Market Share Analysis, 2022 & 2030
• 4.2. Surgical
  • 4.2.1. Surgical Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.2. Chin Implants
    • 4.2.2.1. Chin Implants Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.3. Bone Advancement
    • 4.2.3.1. Bone Advancement Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.3. Non-Surgical
  • 4.3.1. Non-Surgical Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Chin Augmentation Market: Gender Business Analysis

• 5.1. Chin Augmentation Market: Gender Movement & Market Share Analysis, 2022 & 2030
• 5.2. Female
  • 5.2.1. Female Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.3. Male
  • 5.3.1. Male Chin Augmentation Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Chin Augmentation Market: End-Use Business Analysis

• 6.1. Chin Augmentation Market: End Use Movement & Market Share Analysis, 2022 & 2030
• 6.2. Cosmetic Surgery Centers
  • 6.2.1. Cosmetic Surgery Centers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.4. MedSpas
  • 6.4.1. MedSpas Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Chin Augmentation Market: Regional Business Analysis

• 7.1. Regional Market Snapshot
• 7.2. Market Share Analysis by Country, 2022
  • 7.2.1. North America
  • 7.2.2. Europe
  • 7.2.3. Asia Pacific
  • 7.2.4. Latin America
  • 7.2.5. MEA
• 7.3. North America
  • 7.3.1. North America Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • 7.3.2. U.S.
    • 7.3.2.1. U.S. Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.3.2.2. Key Country Dynamics
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
  • 7.3.3. Canada
    • 7.3.3.1. Canada Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.3.3.2. Key Country Dynamics
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
• 7.4. Europe
  • 7.4.1. Europe Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • 7.4.2. Germany
    • 7.4.2.1. Germany Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.2.2. Key Country Dynamics
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
  • 7.4.3. UK
    • 7.4.3.1. UK Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.3.2. Key Country Dynamics
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
  • 7.4.4. France
    • 7.4.4.1. France Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.4.2. Key Country Dynamics
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
  • 7.4.5. Italy
    • 7.4.5.1. Italy Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.5.2. Key Country Dynamics
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
  • 7.4.6. Spain
    • 7.4.6.1. Spain Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.6.2. Key Country Dynamics
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
  • 7.4.7. Denmark
    • 7.4.7.1. Denmark Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.7.2. Key Country Dynamics
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
  • 7.4.8. Sweden
    • 7.4.8.1. Sweden Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.8.2. Key Country Dynamics
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
    • 7.4.8.5.
  • 7.4.9. Norway
    • 7.4.9.1. Norway Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.4.9.2. Key Country Dynamics
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Regulatory Framework
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • 7.5.2. Japan
    • 7.5.2.1. Japan Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.2.2. Key Country Dynamics
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
  • 7.5.3. China
    • 7.5.3.1. China Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.3.2. Key Country Dynamics
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
  • 7.5.4. India
    • 7.5.4.1. India Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.4.2. Key Country Dynamics
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
  • 7.5.5. South Korea
    • 7.5.5.1. South Korea Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.5.2. Key Country Dynamics
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
  • 7.5.6. Australia
    • 7.5.6.1. Australia Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.6.2. Key Country Dynamics
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Regulatory Framework
  • 7.5.7. Thailand
    • 7.5.7.1. Thailand Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.5.7.2. Key Country Dynamics
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Regulatory Framework
• 7.6. Latin America
  • 7.6.1. Latin America Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • 7.6.2. Brazil
    • 7.6.2.1. Brazil Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.6.2.2. Key Country Dynamics
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
  • 7.6.3. Mexico
    • 7.6.3.1. Mexico Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.6.3.2. Key Country Dynamics
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
  • 7.6.4. Argentina
    • 7.6.4.1. Argentina Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.6.4.2. Key Country Dynamics
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
• 7.7. MEA
  • 7.7.1. MEA Chin Augmentation Market, 2018 - 2030 (USD Billion)
  • 7.7.2. South Africa
    • 7.7.2.1. South Africa Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.7.2.2. Key Country Dynamics
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Regulatory Framework
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Saudi Arabia Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.7.3.2. Key Country Dynamics
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Regulatory Framework
    • 7.7.3.5.
  • 7.7.4. UAE
    • 7.7.4.1. UAE Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.7.4.2. Key Country Dynamics
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Regulatory Framework
  • 7.7.5. Kuwait
    • 7.7.5.1. Kuwait Chin Augmentation Market, 2018 - 2030 (USD Billion)
    • 7.7.5.2. Key Country Dynamics
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. New York Plastic Surgical Group
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Westlake Dermatology & Cosmetic Surgery
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Nazarian Plastic Surgery
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Ruby Surgery & Aesthetics
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Cadogan Clinics
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. UK Aesthetic
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. UK Healthcare Aesthetics Center
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Marroquin & Sandoval Plastic Surgery
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Advanced Cosmetic Surgery.
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Orange County Facial Plastic Surgery.
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives

관련자료